Key result
Doxorubicin induces Ca2+ underload in sinus rhythm but Ca2+ overload in tachypaced guinea pig hearts.
Why the study?
The role of intracellular Ca2+ overload in doxorubicin-induced cardiomyopathy and its relation to contractile dysfunction remains disputable.
Does doxorubicin alter intracellular calcium dynamics in guinea pig hearts?
Does doxorubicin alter intracellular calcium dynamics in guinea pig hearts?
Doxorubicin induces calcium underload in sinus rhythm but calcium overload during tachypacing, providing mechanistic insights into doxorubicin-induced cardiomyopathy.
Doxorubicin's Ca2+ effects in guinea pigs warrant clinical caution; hypothesis-generating and leaves open relevance to human cardiomyopathy.
The severe doxorubicin (DOXO) side effect of cardiomyopathy limits it clinical application as an effective anticancer drug. Although Ca2+ overload was postulated as one of the mechanisms for this toxicity, its role was, however, disputable in terms of the contractile dysfunction. In this work, the dynamics of the intracellular Ca2+ signal were optically mapped in a Langendorff guinea pig heart. We found that DOXO treatment: (1) Delayed the activation of the Ca2+ signal. With the reference time set at the peak of the action potential (AP), the time lag between the peak of the Ca2+ signal and AP (Ca-AP-Lag) was significantly prolonged. (2) Slowed down the intracellular Ca2+ releasing and sequestering process. Both the maximum rising (MRV) and falling (MFV) velocity of the Ca2+ signal were decreased. (3) Shortened the duration of the Ca2+ signal in one cycle of Ca2+ oscillation. The duration of the Ca2+ signal at 50% amplitude (CaD50) was significantly shortened. These results suggested a reduced level of intracellular Ca2+ after DOXO treatment. Furthermore, we found that the effect of tachypacing was similar to that of DOXO, and, interestingly, DOXO exerted contradictory effects on the tachypaced hearts: it shortened the Ca-AP-Lag, accelerated the MRV and MFV, and prolonged the CaD50. We, therefore, concluded that DOXO had a different effect on intracellular Ca2+. It caused Ca2+ underload in hearts with sinus rhythm; this might relate to the contractile dysfunction in DOXO cardiomyopathy. It led to Ca2+ overload in the tachypaced hearts, which might contribute to the Ca2+-overload-related toxicity.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied Doxorubicin cardiomyopathy. Doxorubicin (DOXO) was evaluated on Intracellular Ca2+ signal dynamics (Ca-AP-Lag, MRV, MFV, CaD50). Doxorubicin caused Ca2+ underload in guinea pig hearts with sinus rhythm by delaying Ca2+ signal activation and slowing release, but led to Ca2+ overload in tachypaced hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: